Literature DB >> 24712467

Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells.

Hiromasa Morikawa1, Shimon Sakaguchi.   

Abstract

Naturally occurring regulatory T (nTreg) cells, which specifically express the transcription factor Forkhead box protein P3 (FoxP3), are indispensable for the maintenance of immunological self-tolerance and homeostasis. Recent studies have shown that developing nTreg cells in the thymus acquire a Treg-specific and stable hypomethylation pattern in a limited number of genes, which encode key molecules including FoxP3, essential for Treg cell function. This epigenetic change is acquired via T-cell receptor (TCR) stimulation, beginning prior to FoxP3 expression. The Treg-specific DNA hypomethylated regions generally act as gene enhancers in steady state nTreg cells, contributing to the stable expression of Treg function-associated key genes including Ctla4, Il2ra, and Ikzf4 in addition to Foxp3. Upon TCR stimulation of mature nTreg cells, FoxP3 strongly represses many genes including Il2, contributing to Treg suppressive activity. Thus, the Treg-specific epigenome alteration can determine the heritable Treg-specific gene network including Foxp3 regulation. Considering physiological presence of non-suppressive FoxP3(+) T cells in the immune system and loss of FoxP3 in Treg cells under certain immunological conditions, functional nTreg cells can be more accurately defined as a T-cell subpopulation possessing the Treg-type epigenome, rather than FoxP3(+) T cells. This epigenome-based definition of Treg cells would enable better understanding of functional stability, plasticity, and heterogeneity of Treg cells.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA methylation; FoxP3; epigenome; regulatory T cells

Mesh:

Substances:

Year:  2014        PMID: 24712467     DOI: 10.1111/imr.12174

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  68 in total

Review 1.  The multiple pathways to autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Roberto Baccala
Journal:  Nat Immunol       Date:  2017-06-20       Impact factor: 25.606

2.  Gut memories do not fade: epigenetic regulation of lasting gut homing receptor expression in CD4+ memory T cells.

Authors:  B A Szilagyi; J Triebus; C Kressler; M de Almeida; S Tierling; P Durek; M Mardahl; A Szilagyi; S Floess; J Huehn; U Syrbe; J Walter; J K Polansky; A Hamann
Journal:  Mucosal Immunol       Date:  2017-02-15       Impact factor: 7.313

3.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

4.  Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.

Authors:  Luigi Cari; Giuseppe Nocentini; Graziella Migliorati; Carlo Riccardi
Journal:  Oncoimmunology       Date:  2017-11-09       Impact factor: 8.110

Review 5.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

6.  Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma.

Authors:  Gati Asma; Gorrab Amal; Marrakchi Raja; Derouiche Amine; Chebil Mohammed; Ben Ammar Elgaaied Amel
Journal:  Tumour Biol       Date:  2015-01-07

7.  Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells.

Authors:  Aya Shiokawa; Ryutaro Kotaki; Tomohiro Takano; Haruyo Nakajima-Adachi; Satoshi Hachimura
Journal:  Immunology       Date:  2017-06-01       Impact factor: 7.397

Review 8.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

Review 9.  Combining Epigenetic and Immunotherapy to Combat Cancer.

Authors:  Katherine B Chiappinelli; Cynthia A Zahnow; Nita Ahuja; Stephen B Baylin
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

10.  High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.

Authors:  Maran L Sprouse; Marissa A Scavuzzo; Samuel Blum; Ivan Shevchenko; Thomas Lee; George Makedonas; Malgorzata Borowiak; Matthew L Bettini; Maria Bettini
Journal:  JCI Insight       Date:  2018-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.